We conducted a randomized , open-label , single-centre , non-inferiority trial comparing trimethoprim/sulfamethoxazole ( @ mg/@ mg three times daily ) plus rifampicin ( @ mg once a day ) versus linezolid ( @ mg twice a day ) alone in adult patients with various types of MRSA infection .